CompletedPhase 3

Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain

France184 participantsStarted 2015-04

Plain-language summary

Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients requiring endoscopic sinus surgery * ASA score 1 or 2 * patients with health care insurance * approved consent Exclusion Criteria: * any sinonasal malignant tumor * renal failure, hepatic disorder, respiratory deficiency, cardiovascular diseases * neurologic disorders * alcohol or drugs addiction * preoperative facial pain from an extranasal origin * coagulation disorders * antidepressive treatment

What they're measuring

Visual analog scale

Timeframe: at the 2 postoperative hours

Trial details

NCT IDNCT02821169

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06

View on ClinicalTrials.gov More Pain trials